Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapy

Journal of Geriatric Oncology

Volumn 5, Issue 2, 2014, Pages 179-184

  Baitar, Abdelbari ^a   Van Fraeyenhove, Frank ^a   Vandebroek, An ^a   De Droogh, Els ^b   Galdermans, Daniella ^b   Mebis, Jeroen ^b   Schrijvers, Dirk ^a  

^a ZiekenhuisNetwerk Antwerpen   (Belgium)

^b Department of Pulmonology Ziekenhuisnetwerk Antwerpen Middelheim ^*  (Belgium)

Author keywords

Chemotherapy toxicity; G8; Geriatric screening; Groningen frailty indicator

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; DNA TOPOISOMERASE INHIBITOR; PLATINUM COMPLEX; TAXANE DERIVATIVE;

AGED; ARTICLE; BLOOD TOXICITY; BONE CANCER; BREAST CANCER; CANCER OF UNKNOWN PRIMARY SITE; CANCER PALLIATIVE THERAPY; CHEMORADIOTHERAPY; COMORBIDITY; DEATH; DIGESTIVE SYSTEM CANCER; DIZZINESS; DYSPHAGIA; DYSPNEA; FATIGUE; FEMALE; G8 QUESTIONNAIRE; GERIATRIC ASSESSMENT; GRONINGEN FRAILTY INDICATOR; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HUMAN; KIDNEY FAILURE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NONHODGKIN LYMPHOMA; PLEURA EFFUSION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY FAILURE; SCREENING TEST; SOFT TISSUE CANCER; UROGENITAL TRACT CANCER; VOMITING; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT CHEMOTHERAPY; ALGORITHM; CANCER STAGING; FRAIL ELDERLY; GERIATRICS; MORTALITY; NEOPLASMS; ONCOLOGY; PROCEDURES; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALGORITHMS; ANTINEOPLASTIC AGENTS; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; FEMALE; FRAIL ELDERLY; GERIATRIC ASSESSMENT; GERIATRICS; HUMANS; MALE; MEDICAL ONCOLOGY; NEOPLASM STAGING; NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY;

EID: 84896134993     PISSN: 18794068     EISSN: 18794076     Source Type: Journal    
DOI: 10.1016/j.jgo.2013.12.004     Document Type: Article

References (23)

1. Extermann M., Aapro M., Bernabei R., Cohen H.J., Droz J.P., Lichtman S., et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005, 55(3):241-252.
2. Hurria A., Browner I.S., Cohen H.J., Denlinger C.S., deShazo M., Extermann M., et al. Senior adult oncology. J Natl Compr Cancer Netw 2012, 10(2):162-209.
3. Pallis A.G., Fortpied C., Wedding U., Van Nes M.C., Penninckx B., Ring A., et al. EORTC elderly task force position paper: approach to the older cancer patient. Eur J Cancer 2010, 46(9):1502-1513.
4. Puts M.T., Hardt J., Monette J., Girre V., Springall E., Alibhai S.M. Use of geriatric assessment for older adults in the oncology setting: a systematic review. J Natl Cancer Inst 2012, 104(15):1133-1163.
5. Rodin M.B., Mohile S.G. A practical approach to geriatric assessment in oncology. J Clin Oncol 2007, 25(14):1936-1944.
6. Maas H.A., Janssen-Heijnen M.L., Olde Rikkert M.G., Machteld Wymenga A.N. Comprehensive geriatric assessment and its clinical impact in oncology. Eur J Cancer 2007, 43(15):2161-2169.
7. Hamaker M.E., Jonker J.M., de Rooij S.E., Vos A.G., Smorenburg C.H., van Munster B.C. Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol 2012, 13(10):e437-e444.
8. Baitar A., Van Fraeyenhove F., Vandebroek A., De Droogh E., Galdermans D., Mebis J., et al. Evaluation of the Groningen Frailty Indicator and the G8 questionnaire as screening tools for frailty in older patients with cancer. J Geriatr Oncol 2013, 4:32-38.
9. Bellera C.A., Rainfray M., Mathoulin-Pélissier S., Mertens C., Delva F., Fonck M., et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol 2012, 23(8):2166-2172.
10. Pottel L., Boterberg T., Pottel H., Goethals L., Van Den Noortgate N., Duprez F., et al. Determination of an adequate screening tool for identification of vulnerable elderly head and neck cancer patients treated with radio(chemo)therapy. J Geriatr Oncol 2011, 3(1):24-32.
11. Steverink N., Slaets J.P.J., Schuurmans H., Van Lis M. Measuring frailty. Development and testing of the Groningen Frailty Indicator (GFI). Gerontologist 2001, 41(1):236-237.
12. Schuurmans H., Steverink N., Lindenberg S., Frieswijk N., Slaets J.P. Old or frail: what tells us more?. J Gerontol A Biol Sci Med Sci 2004, 59(9):962-965.
13. Repetto L., Fratino L., Audisio R.A., Venturino A., Gianni W., Vercelli M., et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian group for geriatric oncology study. J Clin Oncol 2002, 20(2):494-502.
14. Hurria A., Togawa K., Mohile S.G., Owusu C., Klepin H.D., Gross C.P., et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 2011, 29(25):3457-3465.
15. Mathoulin-Pélissier S., Bellera C., Rainfray M., Soubeyran P. Screening methods for geriatric frailty. Lancet Oncol 2013, 14(1):e1-e2.
16. Extermann M., Chen H., Cantor A.B., Corcoran M.B., Meyer J., Grendys E., et al. Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study. Eur J Cancer 2002, 38(11):1466-1473.
17. Extermann M., Boler I., Reich R.R., Lyman G.H., Brown R.H., Defelice J., et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer 2012, 118(13):3377-3386.
18. Freyer G., Geay J.F., Touzet S., Provencal J., Weber B., Jacquin J.P., et al. Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol 2005, 16(11):1795-1800.
19. Marinello R., Marenco D., Roglia D., Stasi M.F., Ferrando A., Ceccarelli M., et al. Predictors of treatment failures during chemotherapy: a prospective study on 110 older cancer patients. Arch Gerontol Geriatr 2009, 48(2):222-226.
20. Clough-Gorr K.M., Stuck A.E., Thwin S.S., Silliman R.A. Older breast cancer survivors: geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up. J Clin Oncol 2010, 28(3):380-386.
21. Puts M.T., Monette J., Girre V., Pepe C., Monette M., Assouline S., et al. Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study. Crit Rev Oncol Hematol 2011, 78(2):138-149.
22. Hamaker M.E., Vos A.G., Smorenburg C.H., de Rooij S.E., van Munster B.C. The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer. Oncologist 2012, 17(11):1439-1449.
23. Aaldriks A.A., Maartense E., le Cessie S., Giltay E.J., Verlaan H.A., van der Geest L.G., et al. Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy. Crit Rev Oncol Hematol 2011, 79(2):205-212.